MethodAdded (g mL-1 )BCGBTB5.0 10 15 five.0 10Recovery 99.ten 100.20 99.40 99.30 99.50 one Traditional Cytotoxic Agents Source hundred.Precision RSD a 0.42 0.78 1.16 0.53 0.90 1.Intraday Accuracy RE
MethodAdded (g mL-1 )BCGBTB5.0 ten 15 5.0 10Recovery 99.ten 100.20 99.40 99.30 99.50 one hundred.Precision RSD a 0.42 0.78 1.16 0.53 0.90 1.Intraday Accuracy RE -0.90 0.20 -0.60 -0.70 -0.50 0.50 Confidence limitb four.955 0.021 10.02 0.078 14.91 0.173 4.965 0.026 9.95 0.09 20.10 0.231 Recovery 99.60 99.80 99.20 one hundred.60 99.40 99.Precision RSD a 0.51 0.75 1.02 0.40 0.68 0.Interday Accuracy RE -0.40 0.20 -0.80 0.60 -0.60 -0.Confidence limitb four.98 0.025 9.98 0.075 14.88 0.152 5.03 0.020 9.94 0.068 19.92 0.abMean of six determinations; RSD : percentage relative normal deviation; RE : percentage relative error. Self-confidence limit at 95 self-confidence level and 5 degrees of freedom ( = 2.571).Journal of Analytical Strategies in ChemistryJournal of Analytical Approaches in ChemistryTable five: Determination of GMF in its pharmaceutical p70S6K custom synthesis dosage types applying the regular addition technique.Reagent Taken (g mL-1 ) Pure drug added (g mL-1 )two.BCG2.BCP2.BPB2.BTB5.MO4.0 eight.0 12 2.0 6.0 ten 4.0 eight.0 12 4.0 8.0 12 5.0 10Factive tablets Flobiotic tablet GemiQue tablets Total discovered (g mL-1 ) Recovery a SD Total discovered (g mL-1 ) Recovery SD Total found (g mL-1 ) Recovery SD 5.96 99.30 0.78 5.98 99.60 0.67 six.02 100.30 0.51 9.91 99.10 1.02 ten.02 100.20 0.82 9.92 99.20 0.70 13.97 99.80 1.24 13.96 99.70 1.09 13.99 99.90 0.94 3.996 99.90 0.66 3.96 99.ten 0.42 3.97 99.30 0.38 eight.02 one hundred.20 0.90 7.98 99.80 0.69 7.99 99.90 0.84 11.92 99.30 0.95 12.05 100.40 1.03 11.95 99.60 1.17 5.97 99.50 0.57 five.99 99.80 0.36 6.01 100.15 0.76 9.97 99.70 0.76 9.96 99.60 0.49 9.97 99.70 0.96 13.87 99.ten 1.14 13.97 99.90 0.78 13.89 99.20 1.21 six.03 100.50 0.48 6.01 100.10 0.53 six.01 one hundred.10 0.54 9.90 99.00 0.72 9.96 99.60 0.85 9.96 99.60 1.03 13.93 99.50 0.97 13.96 99.70 1.31 14.04 one hundred.30 1.15 9.97 99.70 0.32 9.91 99.ten 0.70 9.99 99.90 0.65 14.94 99.60 0.56 15.06 one hundred.40 1.05 14.97 99.80 0.85 24.95 99.80 0.90 24.88 99.50 1.25 24.90 99.60 1.aAverage of six determinations.Table 6: Determination of MXF in its pharmaceutical dosage forms applying the common addition method.Reagent Taken (g mL-1 ) Pure drug added (g mL-1 )2.BCP2.BPB2.BTB5.MO2.0 6.0 ten four.0 eight.0 12 two.0 four.0 eight.0 five.0 10Avelox tablets Moxiflox tablets Moxifloxacin tablets Total found (g mL-1 ) Recovery a SD Total discovered (g mL-1 ) Recovery SD Total discovered (g mL-1 ) Recovery SD three.98 99.40 0.56 three.96 99.10 0.62 three.98 99.60 0.48 7.98 99.70 0.83 8.06 one hundred.70 0.89 7.98 99.80 1.10 11.89 99.ten 1.20 12.02 one hundred.20 1.26 11.92 99.30 1.17 5.98 99.60 0.61 5.97 99.50 0.35 5.96 99.30 0.36 9.99 99.90 0.84 9.96 99.60 0.60 9.99 99.90 0.63 14.07 one hundred.50 1.14 13.99 99.90 0.85 14.08 one hundred.60 1.36 three.98 99.50 0.48 three.97 99.20 0.33 four.01 100.20 0.61 5.95 99.20 0.92 5.99 99.80 0.65 5.96 99.30 0.84 ten.04 100.40 1.17 ten.01 one hundred.ten 0.93 9.95 99.50 1.07 9.91 99.ten 0.42 9.94 99.40 0.37 9.95 99.50 0.45 15.08 one hundred.50 0.76 15.03 one hundred.20 0.75 14.97 99.80 0.85 19.90 99.50 1.16 19.92 99.60 1.28 19.83 99.15 0.Journal of Analytical Methods in ChemistryaAverage of six determinations.Journal of Analytical Solutions in ChemistryTable 7: Determination of ENF in its pharmaceutical dosage types applying the normal addition strategy. ReagentTaken (g mL-1 ) Pure drug added (g mL-1 ) five.0 BCG five.0 BBTBa5.0 ten 15 5.0 10Enrocin ten injectable Avitryl 20 injectable Total identified (g mL-1 ) Recovery a SD Total discovered (g mL-1 ) Recovery SD 9.92 99.20 0.48 9.94 99.40 0.46 14.94 99.60 0.66 15.20 100.ten 0.72 19.98 10.05 14.91 19.84 99.90 0.82 100.50 0.56 99.40 0.83 99.20 1.20 19.90 9.97 15.05 19.82 99.50.
